Patents by Inventor Steven Averbuch

Steven Averbuch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination methods fo saha and targretin for treating cancer
    Publication number: 20090227674
    Abstract: The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of SAHA or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of Targretin. The SAHA and Targretin may be administered to comprise therapeutically effective amounts.
    Type: Application
    Filed: August 18, 2006
    Publication date: September 10, 2009
    Inventors: Victoria M. Richon, Stanley R. Frankel, Steven Averbuch
  • Method of treating cancers with SAHA and Pemetrexed
    Publication number: 20080269182
    Abstract: The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of an anti-cancer agent. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.
    Type: Application
    Filed: May 20, 2008
    Publication date: October 30, 2008
    Inventors: James Pluda, Stanley R. Frankel, Victoria M. Richon, Steven Averbuch, Judy H. Chiao
  • Method of treating cancers with SAHA and pemetrexed
    Publication number: 20070117815
    Abstract: The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of an anti-cancer agent. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.
    Type: Application
    Filed: November 3, 2006
    Publication date: May 24, 2007
    Inventors: James Pluda, Stanley Frankel, Victoria Richon, Steven Averbuch, Judy Chiao